ResearcherAzienda Ospedaliera Sant'AndreaActive in the last 2 years
Francesco D’Angelo
Matched on ORCID iD 0000-0001-8235-917X; OpenAlex author ID A5034845812. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 7
2016: 1 paper · 2017: 2 papers · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper
Papers 6
- Association of TP53 Arg72Pro (rs1042522) Polymorphism with Pancreatic Cancer Risk in a Patient Cohort Last author DOI 10.3390/onco5040044↗
- Correction to: Is Complete Pathologic Response in Pancreatic Cancer Overestimated? A Systematic Review of Prospective Studies. Co-author DOI 10.1007/s11605-021-05190-z↗
- Can pancreatic cancer be detected by adrenomedullin in patients with new-onset diabetes? The PaCANOD cohort study protocol. Last author DOI 10.5301/tj.5000693↗
- Neoadjuvant treatment in pancreatic cancer: Evidence-based medicine? A systematic review and meta-analysis. Co-author DOI 10.1007/s12032-017-0951-0↗
- Borderline resectable pancreatic cancer: an evolving concept. Co-author DOI 10.1093/annonc/mdx255↗
- Adjuvant and neoadjuvant therapies in resectable pancreatic cancer: a systematic review of randomized controlled trials. Co-author DOI 10.1007/s12032-016-0742-z↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Giovanni Ramacciato · 6 shared papers, 2016–2025 · strength 0.65
- Paper Association of TP53 Arg72Pro (rs1042522) Polymorphism with Pancreatic Cancer Risk in a Patient Cohort DOI 10.3390/onco5040044↗
- Paper Correction to: Is Complete Pathologic Response in Pancreatic Cancer Overestimated? A Systematic Review of Prospective S… DOI 10.1007/s11605-021-05190-z↗
- Paper Can pancreatic cancer be detected by adrenomedullin in patients with new-onset diabetes? The PaCANOD cohort study proto… DOI 10.5301/tj.5000693↗
- Laura Antolino · 5 shared papers, 2016–2025 · strength 0.57
- Paper Association of TP53 Arg72Pro (rs1042522) Polymorphism with Pancreatic Cancer Risk in a Patient Cohort DOI 10.3390/onco5040044↗
- Paper Correction to: Is Complete Pathologic Response in Pancreatic Cancer Overestimated? A Systematic Review of Prospective S… DOI 10.1007/s11605-021-05190-z↗
- Paper Can pancreatic cancer be detected by adrenomedullin in patients with new-onset diabetes? The PaCANOD cohort study proto… DOI 10.5301/tj.5000693↗
- Niccolò Petrucciani · 5 shared papers, 2016–2025 · strength 0.57
- Paper Association of TP53 Arg72Pro (rs1042522) Polymorphism with Pancreatic Cancer Risk in a Patient Cohort DOI 10.3390/onco5040044↗
- Paper Correction to: Is Complete Pathologic Response in Pancreatic Cancer Overestimated? A Systematic Review of Prospective S… DOI 10.1007/s11605-021-05190-z↗
- Paper Borderline resectable pancreatic cancer: an evolving concept. DOI 10.1093/annonc/mdx255↗
- Giuseppe R. Nigri · 4 shared papers, 2017–2025 · strength 0.50
- Paper Association of TP53 Arg72Pro (rs1042522) Polymorphism with Pancreatic Cancer Risk in a Patient Cohort DOI 10.3390/onco5040044↗
- Paper Correction to: Is Complete Pathologic Response in Pancreatic Cancer Overestimated? A Systematic Review of Prospective S… DOI 10.1007/s11605-021-05190-z↗
- Paper Borderline resectable pancreatic cancer: an evolving concept. DOI 10.1093/annonc/mdx255↗
- Germana de Nucci · 1 shared paper, 2025 · strength 0.21
- Gianpiero Manes · 1 shared paper, 2025 · strength 0.21
- Jean Gugenheim · 1 shared paper, 2017 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.